中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2011年
12期
1602-1603
,共2页
前列腺增生%经尿道前列腺汽化电切除术
前列腺增生%經尿道前列腺汽化電切除術
전렬선증생%경뇨도전렬선기화전절제술
Prostatic hyperplasia%Transurethral electrovaporization of prostate
目的 探讨经尿道汽化电切术(TUVP)治疗高危前列腺增生症(BPH)的临床疗效及安全性.方法 回顾性分析采用TUVP治疗的48例高危BPH患者的临床资料,比较术前、术后3个月剩余尿量(PVR)、国际前列腺症状评分(IPSS)、生活质量评分(QOL)等差异.结果 全部患者均安全度过围手术期,术后均获得随访,随访时间3～14个月,48例患者排尿功能恢复良好,无再次排尿困难.患者术前PVR、IPSS、QOL分别为(97.5.±16.9)ml、(28.4±2.3)分、(5.5±0.6)分,术后3个月PVR、IPSS、QOL分别为(30.2±12.3)ml、(8.2±1.3)分、(1.9±0.5)分,手术前后差异均有统计学意义(t=22.31、53.16、31.94,均P<0.05).结论 TUVP治疗高危BPH疗效确切,是一种安全的治疗方法.
目的 探討經尿道汽化電切術(TUVP)治療高危前列腺增生癥(BPH)的臨床療效及安全性.方法 迴顧性分析採用TUVP治療的48例高危BPH患者的臨床資料,比較術前、術後3箇月剩餘尿量(PVR)、國際前列腺癥狀評分(IPSS)、生活質量評分(QOL)等差異.結果 全部患者均安全度過圍手術期,術後均穫得隨訪,隨訪時間3～14箇月,48例患者排尿功能恢複良好,無再次排尿睏難.患者術前PVR、IPSS、QOL分彆為(97.5.±16.9)ml、(28.4±2.3)分、(5.5±0.6)分,術後3箇月PVR、IPSS、QOL分彆為(30.2±12.3)ml、(8.2±1.3)分、(1.9±0.5)分,手術前後差異均有統計學意義(t=22.31、53.16、31.94,均P<0.05).結論 TUVP治療高危BPH療效確切,是一種安全的治療方法.
목적 탐토경뇨도기화전절술(TUVP)치료고위전렬선증생증(BPH)적림상료효급안전성.방법 회고성분석채용TUVP치료적48례고위BPH환자적림상자료,비교술전、술후3개월잉여뇨량(PVR)、국제전렬선증상평분(IPSS)、생활질량평분(QOL)등차이.결과 전부환자균안전도과위수술기,술후균획득수방,수방시간3～14개월,48례환자배뇨공능회복량호,무재차배뇨곤난.환자술전PVR、IPSS、QOL분별위(97.5.±16.9)ml、(28.4±2.3)분、(5.5±0.6)분,술후3개월PVR、IPSS、QOL분별위(30.2±12.3)ml、(8.2±1.3)분、(1.9±0.5)분,수술전후차이균유통계학의의(t=22.31、53.16、31.94,균P<0.05).결론 TUVP치료고위BPH료효학절,시일충안전적치료방법.
Objective To investigate the clinical efficacy and safety of transurthral electrovaporization of the prostate(TUVP) for benign prostatic hyperplasia( BPH) at high risk.Methods Forty-eight patients with BPH at high risk were treated with transurthral electrovaporization of the prostate(TUVP).The clinical data and therapeutic results were measured.Results All patients went through the perioperiative period safely and had been followed up for 3 to 14 months.Postvoid residual ( PVR) , the International Prostate Symptom Score (IPSS) and quality of life (QOL) before operations were (97.5 ± 16.9) ml, ( 28.4 ± 2.3 ) score and (5.5 ±0.6) score respectively.Three months after operation ,PVR ,IPSS and QOL were( 30.2 ± 12.3 ) ml, (8.2 ± 1.3 ) score and( 1.9 ±0.5) score respectively,there was significant difference between them(t =22.31,53.16,31.94,all P<0.05).Conclusion TUVP is an effective and safe method in treating BPH patients at high risk.
